Sabina Marietta Gerber

Title: Innovations of Sabina Marietta Gerber

Introduction

Sabina Marietta Gerber is a notable inventor based in Schlieren, Switzerland. She has made significant contributions to the field of immunogenic compositions, holding two patents that showcase her innovative work. Her inventions focus on modified proteins that enhance stability and yield, which are crucial in the development of effective vaccines.

Latest Patents

Gerber's latest patents include an immunogenic composition that discloses modified ClfA proteins containing glycosylation site consensus sequences. This invention also features a conjugate comprising a modified ClfA protein linked to an antigen, such as a saccharide antigen. Additionally, she has developed another immunogenic composition that reveals modified HIa proteins with a reduced tendency to aggregate, thereby improving protein stability and yield. This patent also includes a conjugate of a modified HIa protein linked to an antigen.

Career Highlights

Sabina Marietta Gerber is currently employed at GlaxoSmithKline Biologicals SA, where she continues to advance her research in immunogenic compositions. Her work is pivotal in the development of new vaccines and therapeutic solutions.

Collaborations

Some of her notable coworkers include Amirreza Faridmoayer and Stefan Jochen Kemmler, who collaborate with her on various projects within the company.

Conclusion

Sabina Marietta Gerber's innovative contributions to the field of immunogenic compositions highlight her role as a leading inventor in the biotechnology sector. Her patents reflect her commitment to improving vaccine efficacy and stability.